Literature DB >> 20671453

Organizational models of emerging academic health science centers in England.

Pavel V Ovseiko1, Stephen M Davies, Alastair M Buchan.   

Abstract

Recent government policy initiatives to foster medical innovation and high-quality care in England have prompted academic and clinical leaders to develop new organizational models to support the tripartite Flexnerian mission of academic medicine. Medical schools and health care providers have responded by aligning their missions and creating integrated governance structures that strengthen their partnerships. In March 2009, the government officially designated five academic-clinical partnerships as England's first academic health science centers (AHSCs). As academic-clinical integration is likely to continue, future AHSC leaders could benefit from an analysis of models for organizing medical school-clinical enterprise relationships in England's emerging AHSCs. In addition, as the United States ponders health systems reform and universal coverage, U.S. medical leaders may benefit from insight into the workings of academic medicine in England's universal health system. In this article, the authors briefly characterize the organization and financing of the National Health Service and how it supports academic medicine. They review the policy behind the designation of AHSCs. Then, the authors describe contrasting organizational models adopted in two of the newly designated AHSCs and analyze these models using a framework derived from U.S. literature. The authors conclude by outlining the major challenges facing academic medicine in England and offer suggestions for future research collaborations between leaders of AHSCs in the United States and England.

Mesh:

Year:  2010        PMID: 20671453     DOI: 10.1097/ACM.0b013e3181e541bd

Source DB:  PubMed          Journal:  Acad Med        ISSN: 1040-2446            Impact factor:   6.893


  8 in total

1.  Academic health sciences centres: an opportunity to improve services, teaching, and research.

Authors:  Brendan Delaney; John Moxham; Robert Lechler
Journal:  Br J Gen Pract       Date:  2010-10       Impact factor: 5.386

2.  Organisational culture and post-merger integration in an academic health centre: a mixed-methods study.

Authors:  Pavel V Ovseiko; Karen Melham; Jan Fowler; Alastair M Buchan
Journal:  BMC Health Serv Res       Date:  2015-01-22       Impact factor: 2.655

3.  Implementation of collaborative governance in cross-sector innovation and education networks: evidence from the National Health Service in England.

Authors:  Pavel V Ovseiko; Catherine O'Sullivan; Susan C Powell; Stephen M Davies; Alastair M Buchan
Journal:  BMC Health Serv Res       Date:  2014-11-08       Impact factor: 2.655

4.  Maximising value from a United Kingdom Biomedical Research Centre: study protocol.

Authors:  Trisha Greenhalgh; Pavel V Ovseiko; Nick Fahy; Sara Shaw; Polly Kerr; Alexander D Rushforth; Keith M Channon; Vasiliki Kiparoglou
Journal:  Health Res Policy Syst       Date:  2017-08-14

5.  The role of academic health centres in building equitable health systems: a systematic review protocol.

Authors:  Alexandra Edelman; Judy Taylor; Pavel V Ovseiko; Stephanie M Topp
Journal:  BMJ Open       Date:  2017-05-29       Impact factor: 2.692

6.  "'Academic' is a dirty word": Intended impact pathways of an emerging academic health centre in tropical regional Australia.

Authors:  Alexandra Edelman; Judy Taylor; Pavel V Ovseiko; Stephanie M Topp
Journal:  Int J Health Plann Manage       Date:  2018-10-12

7.  The role of Academic Health Centers in Transformative Medical Education.

Authors:  José Otávio Costa Auler Júnior; Talita de Almeida; Eduardo Moacyr Krieger
Journal:  Clinics (Sao Paulo)       Date:  2019-09-02       Impact factor: 2.365

8.  Improving accountability through alignment: the role of academic health science centres and networks in England.

Authors:  Pavel V Ovseiko; Axel Heitmueller; Pauline Allen; Stephen M Davies; Glenn Wells; Gary A Ford; Ara Darzi; Alastair M Buchan
Journal:  BMC Health Serv Res       Date:  2014-01-20       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.